As of March 2024 Kindred Biosciences has a market cap of $0.42 Billion. This makes Kindred Biosciences the world's 6200th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.42 B | 0% |
2021 | $0.42 B | 147.33% |
2020 | $0.17 B | -48.86% |
2019 | $0.33 B | -10.57% |
2018 | $0.37 B | 39.7% |
2017 | $0.26 B | 214.37% |
2016 | $84.64 M | 25.5% |
2015 | $67.44 M | -54.1% |
2014 | $0.14 B | -18.87% |
2013 | $0.18 B |
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
Eli Lilly LLY | $739.65 B | 175,788.65% | ๐บ๐ธ USA |
Zoetis ZTS | $77.47 B | 18,323.50% | ๐บ๐ธ USA |
Merck MRK | $334.18 B | 79,367.53% | ๐บ๐ธ USA |
Phibro Animal Health
PAHC | $0.52 B | 24.54% | ๐บ๐ธ USA |
Heska Corporation
HSKA | $1.30 B | 211.41% | ๐บ๐ธ USA |
Petco WOOF | $0.61 B | 45.84% | ๐บ๐ธ USA |